Bai Rilan, Lv Zheng, Chen Xiao, Guo Hanfei, Bai Ling, Tian Huimin, Li Wei, Cui Jiuwei
Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
J Oncol. 2020 Jul 9;2020:9068121. doi: 10.1155/2020/9068121. eCollection 2020.
In recent years, precision medical detection techniques experienced a rapid transformation from low-throughput to high-throughput genomic sequencing, from multicell promiscuous detection to single-cell precision sequencing. The emergence of liquid biopsy technology has compensated for the many limitations of tissue biopsy, leading to a tremendous transformation in precision detection. Precision detection techniques contribute to monitoring disease development more closely, evaluating therapeutic effects more scientifically, and developing new targets and new drugs. In the future, the role of precision detection and the joint detection in epigenetics, rare gene detection, individualized targeted therapy, and multigene targeted drug combination therapy should be extensively explored. This article reviews the changes in precision medical detection technology in the era of precision medicine, as well as the development, clinical application, and future challenges of liquid biopsy.
近年来,精准医学检测技术经历了从低通量到高通量基因组测序、从多细胞混杂检测到单细胞精准测序的快速转变。液体活检技术的出现弥补了组织活检的诸多局限性,带来了精准检测的巨大变革。精准检测技术有助于更密切地监测疾病发展、更科学地评估治疗效果以及开发新靶点和新药物。未来,应广泛探索精准检测及联合检测在表观遗传学、罕见基因检测、个体化靶向治疗和多基因靶向药物联合治疗中的作用。本文综述了精准医学时代精准医学检测技术的变化,以及液体活检的发展、临床应用和未来挑战。